Related Experiment Video
Updated: May 7, 2026

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
Published on: July 6, 2013
Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development
Sushant Sahastrabuddhe1, Rodney Carbis, Thomas F Wierzba
1International Vaccine Institute, San 4-8, Nakseongdae-dong, Gwanak-gu, Seoul, 151-919, Korea.
Abstract:
Enteric fever caused by Salmonella enterica serovar Typhi and Salmonella enterica serovar Paratyphi is still a major disease burden mainly in developing countries. Previously, S. Typhi was believed to be the major cause of enteric fever. The real situation is now becoming clear with reports emerging from many Asian countries of S. Paratyphi, mostly S. Paratyphi A, causing a substantial number of cases of enteric fever. Although there have been advances in the use of the currently available typhoid vaccines and in the development of newer typhoid vaccines, paratyphoid vaccine development is lagging behind. Since the disease caused by S. Typhi and S. Paratyphi are clinically indistinguishable and are commonly termed 'enteric' fever, it will be necessary to have a vaccine available against both S. Typhi and S. Paratyphi A as a bivalent 'enteric fever vaccine'.
Related Concept Videos
Vaccinations
Vaccine Production
Clinical Significance of Antibiotic Resistance
Reservoir of Infection
Microorganisms in Medicine and Therapeutics
Investigation of Disease Outbreaks
